PD-1, a receptor for B7-4, and uses therefor
Details for Australian Patent Application No. 2002338272 (hide)
International Classifications
Event Publications
20 February 2003 Complete Application Filed
Priority application(s): 60/281,064 02.04.01 US
3 April 2003 Application Open to Public Inspection
Published as AU-B-2002338272
30 October 2003 Amendment Made
The nature of the amendment is: Amend the name of the co-applicant from Dana-Farber Cancer Institute to Dana-Farber Cancer Institute, Inc. 2003
11 October 2007 Application Accepted
Published as AU-B-2002338272
7 February 2008 Standard Patent Sealed
30 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002338273-Computer aided system for designing a hearing aid housing
2002338271-ELECTROPHORETIC MEDIUM WITH IMPROVED IMAGE STABILITY
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser